| Financial Year |
March 31 2023 |
| Monetary Funds |
254,366,962.45 |
| Held-for-trading Financial Assets |
30,142,520.55 |
| Notes Receivable |
71,891,160.20 |
| Accounts Receivable |
421,433,391.42 |
| Advances to Suppliers |
5,122,492.56 |
| Other Receivables |
5,758,833.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
400,399,775.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,201,738.11 |
| Total Current Assets |
1,277,375,566.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,584,012.54 |
| Fixed Assetes |
564,121,450.39 |
| Under-construction Projects |
31,228,913.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,152,628.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
132,258.63 |
| Deferred Income Tax Assets |
12,313,498.01 |
| Other Non-Current Assets |
580,850.38 |
| Sub-Total of Non-Current Assets |
697,594,197.83 |
| Total Assets |
1,974,969,763.99 |
| Short-Term Loans |
50,677,027.66 |
| Trading Financial liabilities |
240,443.67 |
| Notes Payable |
118,083,326.55 |
| Accounts Payable |
289,250,174.06 |
| Accounts Received In Advance |
1,225,950.46 |
| Employee Compensation Payable |
25,654,333.24 |
| Taxes Payable |
7,159,319.61 |
| Interest Payable |
1,746,654.22 |
| Dividend Payable |
-- |
| Other payables |
2,923,790.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
961,587.14 |
| Other Current Liabilities |
38,842.53 |
| Sub-Total of Current Liabilities |
496,918,990.47 |
| Long-term Loans |
-- |
| Bonds Payable |
305,469,409.12 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,023.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
345,967,727.40 |
| Total Liabilities |
842,886,717.87 |
| Paid-In Capital(Or Share Stock) |
192,143,072.00 |
| Capital Surplus |
446,043,448.28 |
| Surplus Reserve |
72,541,428.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
343,862,408.59 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,132,083,046.12 |
| Owner's Equity（Stockholder's Equity） |
1,132,083,046.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,974,969,763.99 |
